SEC 13F Intelligence

Managers / Q4 2022 · view latest →

BRANDYWINE MANAGERS, LLC

CIK 0001135121 · 7234 LANCASTER PIKE, HOCKESSIN, DE, 19707 · 302-234-5705

Reported Value
$29M
Q4 2022
Positions
37
Filings on Record
30
2019–present window
Filed
Feb 14, 2023
original filing

Summary

Brandywine Managers, LLC reported $29M in U.S.-listed holdings across 37 positions for Q4 2022.

Its largest position, PATH, represents 19.3% of the portfolio.

Compared with Q3 2022, the fund opened 2 new positions and exited 4.

Portfolio Metrics

Turnover
+10.5%
vs prior filed quarter
Top-10 Concentration
+60.1%
share of reported value
Largest Position
+19.3%
Uipath
New / Exited
2 / 4
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $212MQ4 ’18Q1 ’19: $250MQ2 ’19: $267MQ3 ’19: $299MQ4 ’19: $334MQ4 ’19Q1 ’20: $284MQ2 ’20: $24MQ3 ’20: $53MQ4 ’20: $73MQ4 ’20Q1 ’21: $75MQ2 ’21: $88MQ3 ’21: $96MQ4 ’21: $88MQ4 ’21Q1 ’22: $58MQ2 ’22: $41MQ3 ’22: $30MQ4 ’22: $29MQ4 ’22Q1 ’23: $141MQ2 ’23: $151MQ3 ’23: $59MQ4 ’23: $91MQ4 ’23Q1 ’24: $101MQ2 ’24: $95MQ3 ’24: $93MQ4 ’24: $95MQ4 ’24Q1 ’25: $83MQ2 ’25: $101MQ3 ’25: $104MQ4 ’25: $202MQ4 ’25Q1 ’26: $170Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $29M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PRMEPRIME MEDICINE INCNEW+33.0K33.0K+$612,713$612,713
MBLYMOBILEYE GLOBAL INCNEW+13.1K13.1K+$458,129$458,129
ISIIONIS PHARMACEUTICALS INCSOLD OUT−8.5K0−$374,000$0
VRNSVARONIS SYS INCSOLD OUT−13.6K0−$360,000$0
SSENTINELONE INCSOLD OUT−7.9K0−$202,000$0
SEERSEER INCSOLD OUT−15.4K0−$119,000$0
BERKELEY LTS INCTRIMMED−25.0K29.8K−$77,211$79,789
BEAMBEAM THERAPEUTICS INCTRIMMED−5.0K8.1K−$307,500$315,500

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2022

37 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1PATHUIPATH INChistory →CL A19.31%$6M434.8K
2CRWDCROWDSTRIKE HLDGS INChistory →CL A10.55%$3M28.7K
3MRNAMODERNA INChistory →COM5.97%$2M9.5K
4CPBCAMPBELL SOUP COhistory →COM4.76%$1M24.0K
5ALNYALNYLAM PHARMACEUTICALS INChistory →COM3.83%$1M4.6K
6MAMASTERCARD INCORPORATEDhistory →CL A3.34%$956,2582.8K
7ISRGINTUITIVE SURGICAL INChistory →COM NEW3.24%$927,3983.5K
8CRMSALESFORCE INChistory →COM3.20%$916,5956.9K
9NTRANATERA INChistory →COM3.02%$865,02121.5K
10PDPAGERDUTY INChistory →COM2.83%$810,53230.5K
11ZSZSCALER INChistory →COM2.74%$783,3007.0K
12OKTAOKTA INChistory →CL A2.45%$700,24610.2K
13VEEVVEEVA SYS INChistory →CL A COM2.21%$632,4483.9K
14PRMEPRIME MEDICINE INChistory →COM2.14%$612,71333.0K
15ABCLABCELLERA BIOLOGICS INChistory →COM2.02%$577,16757.0K
16DDOGDATADOG INChistory →CL A COM1.85%$529,2007.2K
17AMDADVANCED MICRO DEVICES INChistory →COM1.83%$524,5728.1K
18NVDANVIDIA CORPORATIONhistory →COM1.82%$520,8433.6K
19PANWPALO ALTO NETWORKS INChistory →COM1.81%$516,9963.7K
20TWSTTWIST BIOSCIENCE CORPhistory →COM1.74%$499,29621.0K
21TWLOTWILIO INChistory →CL A1.67%$478,9279.8K
22RLAYRELAY THERAPEUTICS INChistory →COM1.66%$475,19731.8K
23MBLYMOBILEYE GLOBAL INChistory →COMMON CLASS A1.60%$458,12913.1K
24GHGUARDANT HEALTH INChistory →COM1.51%$433,37815.9K
25TXG10X GENOMICS INChistory →CL A COM1.43%$408,42011.2K
26SDGRSCHRODINGER INChistory →COM1.36%$390,35920.9K
27SNOWSNOWFLAKE INChistory →CL A1.28%$365,8832.5K
28NOWSERVICENOW INChistory →COM1.21%$346,725893
29IOTSAMSARA INChistory →COM CL A1.11%$317,93525.6K
30BEAMBEAM THERAPEUTICS INChistory →COM1.10%$315,5008.1K
31SMARGBPSMARTSHEET INChistory →COM CL A1.06%$303,0727.7K
32DNLIDENALI THERAPEUTICS INCCOM0.93%$267,0049.6K
33QTRXQUANTERIX CORPCOM0.92%$264,05019.1K
34DOCUDOCUSIGN INCCOM0.82%$233,3744.2K
35RBLXROBLOX CORPCL A0.72%$206,0797.2K
36FULCFULCRUM THERAPEUTICS INCCOM0.66%$190,20526.1K
37BERKELEY LTS INCCOM0.28%$79,78929.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$170M40May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$202M38Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$104M37Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$101M36Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$83M35May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$95M37Feb 13, 202513F-HRchanges · EDGAR ↗
Q3 2024$93M35Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$95M36Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$101M40May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$91M42Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$59M38Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$151M48Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$141M48May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$29M37Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$30M39Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$41M42Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$58M42May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$88M43Feb 10, 202213F-HRchanges · EDGAR ↗
Q3 2021$96M44Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$88M45Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$75M46May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$73M42Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$53M40Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$24M40Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$284M38May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$334M49Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$299M48Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$267M48Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$250M48May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$212M46Feb 12, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 5 additional managers.

  • GARDNER RUSSO & QUINN LLC028-02635
  • PARAMETRIC PORTFOLIO ASSOCIATES LLC028-04558
  • ABANCO INVESTORS LTD., LLC028-06287
  • BrandyTrust Global Partners, LP028-18174
  • Evercore Wealth Management, LLC028-13662

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.